YEAR | COMPANY | POSITION | SALARY | INCREMENT |
---|---|---|---|---|
2024 | Disc Medicine Inc | Independent Director | 330.2 K | 25.6 % |
2023 | Disc Medicine Inc | Independent Director | 262.8 K | 385.0 % |
2023 | Iterum Therapeutics Plc | Independent Director | 68.5 K | -56.8 % |
2022 | Iterum Therapeutics Plc | Independent Director | 158.5 K | 0.0 % |
2022 | Harpoon Therapeutics Inc | Independent Director | 59.6 K | -71.1 % |
2022 | Disc Medicine Inc | Independent Director | 54.2 K | - |
2022 | Pyxis Oncology Inc | Independent Director | 11.1 K | -98.3 % |
2022 | Pyxis Oncology Inc | Independent Director | - | - |
2021 | Pyxis Oncology Inc | Independent Director | 638.8 K | - |
2021 | Harpoon Therapeutics Inc | Independent Director | 206.4 K | 114.6 % |
2021 | Iterum Therapeutics Plc | Independent Director | 158.5 K | 1207.2 % |
2020 | Harpoon Therapeutics Inc | Independent Director | 96.1 K | -37.3 % |
2020 | Iterum Therapeutics Plc | Independent Director | 12.1 K | -90.6 % |
2020 | Pyxis Oncology Inc | Independent Director | - | - |
2019 | Harpoon Therapeutics Inc | Independent Director | 153.2 K | 425.7 % |
2019 | Iterum Therapeutics Plc | Independent Director | 128.5 K | 17.4 % |
2018 | Iterum Therapeutics Plc | Independent Director | 109.4 K | - |
2018 | Harpoon Therapeutics Inc | Independent Director | 29.1 K | - |
2017 | Iterum Therapeutics Plc | Director | - | - |